MEL 90
Device
Carl Zeiss Meditec, Inc.
Total Payments
$2.3M
Transactions
193
Doctors
32
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $74,591 | 16 | 13 |
| 2023 | $60,885 | 3 | 3 |
| 2022 | $135,000 | 10 | 2 |
| 2021 | $350,072 | 31 | 3 |
| 2020 | $1.7M | 103 | 9 |
| 2019 | $3,783 | 30 | 15 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.5M | 90 | 64.3% |
| Consulting Fee | $726,559 | 50 | 31.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83,897 | 17 | 3.6% |
| Travel and Lodging | $6,139 | 13 | 0.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,990 | 2 | 0.1% |
| Food and Beverage | $407.69 | 21 | 0.0% |
Payments by Type
Research
$1.5M
90 transactions
General
$819,994
103 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. | Carl Zeiss Meditec, Inc. | $1.5M | 4 |
| A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. | Carl Zeiss Meditec USA, Inc. | $814.00 | 1 |
Top Doctors Receiving Payments for MEL 90
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Sioux Falls, SD | $901,984 | 64 |
| , MD | Corneal and Contact Management | New York, NY | $593,080 | 40 |
| , MD | Ophthalmology | Greenwood Village, CO | $541,597 | 21 |
| , M.D | Ophthalmology | Temple, TX | $155,668 | 6 |
| , MD | Ophthalmology | Leawood, KS | $75,251 | 13 |
| , M.D | Ophthalmology | New Albany, IN | $7,922 | 3 |
| , M.D | Ophthalmology | Bloomington, MN | $2,607 | 3 |
| , OD | Optometrist | Rogers, MN | $2,138 | 11 |
| , OD | Ophthalmology | Los Angeles, CA | $1,950 | 1 |
| , M.D | Ophthalmology | Memphis, TN | $1,500 | 1 |
| , O.D | Optometrist | Sioux Falls, SD | $1,452 | 5 |
| , MD | Ophthalmology | Lafayette, IN | $1,215 | 1 |
| , M.D | Ophthalmology | Mt Pleasant, SC | $1,200 | 1 |
| , M.D | Ophthalmology | Cleveland, OH | $1,068 | 2 |
| , MD | Ophthalmology | Highland Park, IL | $1,050 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Brecksville, OH | $1,050 | 1 |
| , MD | Cornea and External Diseases Specialist | City Of Industry, CA | $1,040 | 1 |
| , MD | Ophthalmology | Amherst, NY | $1,020 | 1 |
| , MD | Ophthalmology | Bellevue, WA | $1,020 | 1 |
| , MD | Ophthalmology | Irving, TX | $990.00 | 1 |
| , MD | Ophthalmology | Brecksville, OH | $975.00 | 1 |
| , M.D | Ophthalmology | Towson, MD | $900.00 | 1 |
| , M.D | Ophthalmology | Phoenix, AZ | $900.00 | 1 |
| , M.D | Ophthalmology | San Antonio, TX | $814.00 | 1 |
| , M.D | Ophthalmology | Long Beach, CA | $765.00 | 1 |
Ad
Manufacturing Companies
- Carl Zeiss Meditec, Inc. $1.7M
- Carl Zeiss Meditec AG $593,009
- Carl Zeiss Meditec USA, Inc. $13,020
Product Information
- Type Device
- Total Payments $2.3M
- Total Doctors 32
- Transactions 193
About MEL 90
MEL 90 is a device associated with $2.3M in payments to 32 healthcare providers, recorded across 193 transactions in the CMS Open Payments database. The primary manufacturer is Carl Zeiss Meditec, Inc..
Payment data is available from 2019 to 2024. In 2024, $74,591 was paid across 16 transactions to 13 doctors.
The most common payment nature for MEL 90 is "Unspecified" ($1.5M, 64.3% of total).
MEL 90 is associated with 2 research studies, including "A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism." ($1.5M).